Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Fight INflammation to Improve outcome after aneurysmal Subarachnoid HEmorRhage (FINISHER) trial: Study protocol for a randomized controlled trial

Title: Fight INflammation to Improve outcome after aneurysmal Subarachnoid HEmorRhage (FINISHER) trial: Study protocol for a randomized controlled trial
Authors: Güresir, Erdem; Lampmann, Tim; Bele, Sylvia; Czabanka, Marcus; Czorlich, Patrick; Gempt, Jens; Goldbrunner, Roland; Hurth, Helene; Hermann, Elvis; Jabbarli, Ramazan; Krauthausen, Marius; König, Ralph; Lindner, Dirk; Malinova, Vesna; Meixensberger, Jürgen; Mielke, Dorothee; Németh, Robert; Darkwah Oppong, Marvin; Pala, Andrej; Prinz, Vincent; Rashidi, Ali; Roder, Constantin; Sandalcioglu, Ibrahim Erol; Sauvigny, Thomas; Schebesch, Karl-Michael; Timmer, Marco; Vajkoczy, Peter; Wessels, Lars; Wild, Florian; Wilhelm, Christoph; Wostrack, Maria; Vatter, Hartmut; Coch, Christoph
Publisher Information: SAGE
Publication Year: 2023
Collection: Universität Leipzig: Qucosa
Subject Terms: Dexamethasone; glucocorticoid; aneurysm; subarachnoid hemorrhage; inflammation; clinical trail; info:eu-repo/classification/ddc/610; ddc:610
Description: Aneurysmal subarachnoid hemorrhage (SAH) has high morbidity and mortality. While the primary injury results from the initial bleeding cannot currently be influenced, secondary injury through vasospasm and delayed cerebral ischemia worsens outcome and might be a target for interventions to improve outcome. To date, beside the aneurysm treatment to prevent re-bleeding and the administration of oral nimodipine, there is no therapy available, so novel treatment concepts are needed. Evidence suggests that inflammation contributes to delayed cerebral ischemia and poor outcome in SAH. Some studies suggest a beneficial effect of anti-inflammatory glucocorticoids, but there are no data from randomized controlled trials examining the efficacy of glucocorticoids. Therefore, current guidelines do not recommend the use of glucocorticoids in SAH.
Document Type: article in journal/newspaper
Language: English
Relation: https://ul.qucosa.de/id/qucosa%3A97553
Availability: https://nbn-resolving.org/urn:nbn:de:bsz:15-qucosa2-975532; https://ul.qucosa.de/id/qucosa%3A97553; https://ul.qucosa.de/api/qucosa%3A97553/attachment/ATT-0/
Rights: info:eu-repo/semantics/openAccess
Accession Number: edsbas.67B305F9
Database: BASE